OR WAIT null SECS
Growth and Advancements in Fill/Finish
Employing novel technologies and more patient-centric approaches
Delving into Biopharmaceutical Development and Manufacturing
Quality Considerations in Changing Excipient Providers
May 12, 2023
In a deal potentially worth more than $530 million, Amgen will use TScan Therapeutics’ target discovery platform to home in on novel targets for Crohn’s disease treatment.
Dr. Ulrike Lemke, Head of Sterile Fill Finish at Recipharm, sat down with Grant Playter, associate editor, to discuss drug delivery forms.
Congress have initiated a range of legislative proposals to further manage PBMs and the pharma market.
The new partnership between Sandoz, a Novartis division, and Just – Evotec Biologics will aim to develop and manufacture multiple biosimilars.
May 11, 2023
The objective of the partnership is to automate portions of ScaleReady’s CGT manufacturing workflow by using Cellular Origin’s robotic system for sterile liquid transfer.
EC has granted marketing authorization to Chiesi Global Rare Diseases and Protalix BioTherapeutics for PRX-102 (pegunigalsidase alfa).
Critical raw materials supplier, Biosynth, has acquired UK-based Cambridge Research Biochemicals (CRB).
Vetter is further expanding its production capacity and services at its Rankweil, Austria site.
May 10, 2023
The guidance is to provide information on compliance with applicable regulatory requirements and recommendations.
EMA and European regulators are lifting their COVID-19 business continuity measures as the pandemic’s peak ends.